Market Place
Sourcing Support
FDA Has Accepted the New Drug Application (NDA) for Ensartinib
13 Mar 2024 //
BUSINESSWIRE
Xcovery SHP2 Inhibitor IND Approved by US FDA
23 May 2022 //
BIOSPACE
Xcovery Acquires Majority Controlling Stake in Meryx Pharmaceuticals
07 Dec 2021 //
BUSINESSWIRE
Xcovery Announces the Appointment of Giovanni Selvaggi as CEO
18 Mar 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.